{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T01:18:10Z","timestamp":1670375890613},"reference-count":12,"publisher":"Japanese Society of Internal Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,3,1]]},"DOI":"10.2169\/internalmedicine.1607-18","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T22:30:32Z","timestamp":1539729032000},"page":"649-654","source":"Crossref","is-referenced-by-count":4,"title":["Crohn's Disease with Mesalazine Allergy that Was Difficult to Differentiate from Comorbid Ulcerative Colitis"],"prefix":"10.2169","volume":"58","author":[{"given":"Rumiko","family":"Tsuboi","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Saitama Medical Center, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satohiro","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Saitama Medical Center, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Miyatani","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Saitama Medical Center, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirosato","family":"Mashima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Saitama Medical Center, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Hanauer S, Schwartz J, Robinson M, et al. Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group. Am J Gastroenterol 88: 1188-1197, 1993."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Gupta MK, Pollack S, Hutchings JJ. Mesalamine induced symptom exacerbation of ulcerative colitis: case report and brief discussion. World J Gastrointest Pharmacol Ther 1: 132-134, 2010.","DOI":"10.4292\/wjgpt.v1.i6.132"},{"key":"3","unstructured":"3. Motoya S, Simodate Y, Tanaka H, Imamura A. Mesalamine intolerance of ulcerative colitis. IBD Research 4: 127-131, 2010 (in Japanese)."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Saito D, Hayashida M, Sato T, et al. Evaluation of the drug-induced lymphocyte stimulation test for diagnosing mesalazine allergy. Intest Res 16: 273-281, 2018.","DOI":"10.5217\/ir.2018.16.2.273"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Sturgeon JB, Bhatia P, Hermens D, Miner PB Jr. Exacerbation of chronic ulcerative colitis with mesalamine. Gastroenterology 108: 1889-1893, 1995.","DOI":"10.1016\/0016-5085(95)90154-X"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Akhmaltdinova LL, Gazalieva MA, Akhmetova SB. Levels of cytokines in drug hypersensitivity. Cent Eur J Immunol 42: 354-357, 2017.","DOI":"10.5114\/ceji.2017.72809"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Gramlich T, Petras RE. Pathology of inflammatory bowel disease. Semin Pediatr Surg 16: 154-163, 2007.","DOI":"10.1053\/j.sempedsurg.2007.04.005"},{"key":"8","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0016-5085(90)91241-W","volume":"99","author":"PM Griffin","year":"1990","unstructured":"8. Griffin PM, Olmstead LC, Petras RE. Escherichia coli O157:H7-associated colitis. A clinical and histological study of 11 cases. Gastroenterology 99: 142-149, 1990.","journal-title":"Gastroenterology","ISSN":"http:\/\/id.crossref.org\/issn\/0016-5085","issn-type":"print"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Torii Y, Katano Y, Yoshino J, et al. A case of diverticular colitis with lesions resembling ulcerative colitis and correlation of tumor necrosis factor-alpha staining with clinical manifestations. Clin J Gastroenterol 8: 377-384, 2015.","DOI":"10.1007\/s12328-015-0608-5"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Kapur KC, Williams GT, Allison MC. Mesalazine induced exacerbation of ulcerative colitis. Gut 37: 838-839, 1995.","DOI":"10.1136\/gut.37.6.838"},{"key":"11","unstructured":"11. Motoya S, Miyakawa M, Nasuno M, Tanaka H. Approach for mesalamine intolerance. IBD Research 9: 17-286, 2015 (in Japanese)."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Fernando G, Axel D, Vito A, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: Part 1: diagnosis and medical management. J Crohn's Colitis 11: 3-25, 2017.","DOI":"10.1093\/ecco-jcc\/jjw168"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/5\/58_1607-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,2]],"date-time":"2019-03-02T05:40:54Z","timestamp":1551505254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/5\/58_1607-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,1]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1607-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,1]]}}}